Skip to main content

Table 1 Characteristics of mCRC patients.

From: Low Percentage of KRAS Mutations Revealed by Locked Nucleic Acid Polymerase Chain Reaction: Implications for Treatment of Metastatic Colorectal Cancer

 

KRAS wild-type

KRAS mutated

n

129

84

Age, median (range)

62

77

 

(39–86)

(37–88)

Sex

  

M

74

46

F

55

38

Primary tumor site

  

Colon

107

73

Rectum

22

11

Tissue for KRAS analysis

  

Primary

105

69

Metastases

24

15

Back to article page

Molecular Medicine

ISSN: 1528-3658